Clinical Trial Update: A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract Infections [Phase 2]

View source ↗

Summary

Phase 2 pediatric study evaluating pharmacokinetics and tolerability of Vaborem (meropenem/vaborbactam) in children with Gram-negative infections, including com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Vaborem (meropenem/vaborbactam)

Snippet

Sponsor: Menarini Group | Conditions: Gram Negative Infections | Phase 2 | Status: RECRUITING